Frontiers in thoracic oncology: new breakthroughs in molecular targets and immunotherapy.
1/5 보강
Thoracic tumors, including lung cancer, breast cancer, and thymoma, usually present poor outcomes.
APA
Yang Y, Pu D, Li X (2025). Frontiers in thoracic oncology: new breakthroughs in molecular targets and immunotherapy.. Frontiers in immunology, 16, 1721638. https://doi.org/10.3389/fimmu.2025.1721638
MLA
Yang Y, et al.. "Frontiers in thoracic oncology: new breakthroughs in molecular targets and immunotherapy.." Frontiers in immunology, vol. 16, 2025, pp. 1721638.
PMID
41472727 ↗
Abstract 한글 요약
Thoracic tumors, including lung cancer, breast cancer, and thymoma, usually present poor outcomes. The current treatment methods for thoracic tumors have low efficacy and are associated with severe adverse reactions. Molecular targeted therapy and immunotherapy offer new possibilities for the treatment of thoracic tumors. In this review, we have summarized the latest research on these novel therapeutic strategies, and discussed their clinical applications, challenges, and possible countermeasures. This review offers a theoretical basis for improving the outcomes of thoracic tumor patients, along with future research prospects.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Super-selective intra-arterial dissolution therapy for lingual artery occlusion resulting due to the use of hyaluronic acid for chin augmentation: The first reported case.
- NAT10 and ac4C modification in cancer immunity and metabolism: emerging mechanisms and therapeutic potential.
- Engineering polymeric RNA scaffolds as programmable combinatorial innate immune agonists.
- HDAC11 interacts with the NuRD (MTA3) complex to transcriptionally suppress TGFβ1 expression and inhibit hepatocellular carcinoma metastasis.
- Targeting palmitoylation: A novel frontier in cancer biology and immunotherapy.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.